한글목차

여성 건강 진단 동향과 예측

세계 여성 건강 진단 시장은 2024년부터 2030년까지 8.1%의 CAGR로 2030년까지 약 488억 2,000 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 여성의 감염성 질환의 높은 유병률과 POC 검사에 대한 적응증 확대입니다. 세계 여성 건강 진단 시장의 미래는 병원 및 클리닉, 진단 및 영상 센터, 재택 의료 시장에서의 비지니스 기회로 인해 유망합니다.

여성 건강 진단 시장 인사이트

Lucintel의 예측에 따르면, 유방암의 높은 발생률과 Abs와 같은 첨단 유방암 진단 기술에 대한 인식이 높아짐에 따라 유방암이 예측 기간 동안 가장 높은 성장률을 기록할 것으로 예상됩니다.

재택의료는 자가진단키트 사용의 이점이 증가함에 따라 이 시장에서 가장 큰 비중을 차지할 것으로 보입니다.

북미 지역은 여성 암 유병률 증가로 인해 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다:

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장의 주요 과제와 비지니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비지니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 여성 건강 진단 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 여성 건강 진단 시장 동향(2018-2023)과 예측(2024-2030)
• 최종 이용 산업별 세계 여성 건강 진단 시장
  • 병원과 클리닉
  • 진단 센터와 영상 센터
  • 재택 케어
  • 기타
• 용도별 세계 여성 건강 진단 시장
  • 골다공증 검사
  • OVC 테스트
  • 자궁경부암 검사
  • 유방암 검사
  • 임신과 불임 검사
  • 출생전 유전자 스크리닝과 보인자 검사
  • 감염증 검사
  • 성병 검사
  • 초음파 검사

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 여성 건강 진단 시장
• 북미의 여성 건강 진단 시장
• 유럽의 여성 건강 진단 시장
• 아시아태평양의 여성 건강 진단 시장
• 기타 지역 여성 건강 진단 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 최종 이용 산업별 세계 여성 건강 진단 시장 성장 기회
  • 용도별 세계 여성 건강 진단 시장 성장 기회
  • 지역별 세계의 여성 건강 진단 시장 성장 기회
• 세계의 여성 건강 진단 시장의 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 여성 건강 진단 시장 능력 확대
  • 세계의 여성 건강 진단 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• F. Hoffmann-la Roche
• Siemens Aktiengesellschaft
• Quest Diagnostics Incorporated
• Ge Healthcare
• Koninklijke Philips
• General Motors
• Abbott Laboratories
• Becton
• Dickinson
• Hologic

영문목차

Womens Health Diagnostic Trends and Forecast

The future of the global womens health diagnostic market looks promising with opportunities in the hospitals & clinics, diagnostic and imaging centers, and home care settings markets. The global womens health diagnostic market is expected to reach an estimated $48.82 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are high prevalence of infectious diseases in women and growing adaption of POC dignostic testing.

A more than 150-page report is developed to help in your business decisions.

Womens Health Diagnostic by Segment

The study includes a forecast for the global womens health diagnostic by end use industry, application, and region.

Womens Health Diagnostic Market by End Use Industry Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Diagnostic & Imaging Centers
• Home Care Settings
• Others

Womens Health Diagnostic Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Osteoporosis Testing
• OVC Testing
• Cervical Cancer Testing
• Breast Cancer Testing
• Pregnancy & Fertility Testing
• Prenatal Genetic Screening & Carrier Testing
• Infectious Disease Testing
• STD Testing
• Ultrasound Tests
• Others

Womens Health Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Womens Health Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies womens health diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the womens health diagnostic companies profiled in this report include-

• F. Hoffmann-La Roche
• Siemens Aktiengesellschaft
• Quest Diagnostics Incorporated
• GE Healthcare
• Koninklijke Philips
• General Motors
• Abbott Laboratories
• Becton
• Dickinson
• Hologic

Womens Health Diagnostic Market Insights

Lucintel forecasts that breast cancer is expected to witness highest growth over the forecast period due to high occurrence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as abus.

Within this market, home care settings will remain the largest segment due to increasing advantages of using self-testing kits.

North America is expected to witness highest growth over the forecast period due to increasing prevalence of cancer among women.

Features of the Global Womens Health Diagnostic Market

Market Size Estimates: Womens health diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Womens health diagnostic market size by end use industry, application, and region in terms of value ($B).

Regional Analysis: Womens health diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different end use industry, application, and regions for the womens health diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the womens health diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the womens health diagnostic market size?

Answer: The global womens health diagnostic market is expected to reach an estimated $48.82 billion by 2030.

Q.2 What is the growth forecast for womens health diagnostic market?

Answer: The global womens health diagnostic market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the womens health diagnostic market?

Answer: The major drivers for this market are high prevalence of infectious diseases in women and growing adaption of POC dignostic testing.

Q4. What are the major segments for womens health diagnostic market?

Answer: The future of the womens health diagnostic market looks promising with opportunities in the hospitals & clinics, diagnostic and imaging centers, and home care settings markets.

Q5. Who are the key womens health diagnostic market companies?

Answer: Some of the key womens health diagnostic companies are as follows:

• F. Hoffmann-La Roche
• Siemens Aktiengesellschaft
• Quest Diagnostics Incorporated
• Ge Healthcare
• Koninklijke Philips
• General Motors
• Abbott Laboratories
• Becton
• Dickinson
• Hologic

Q6. Which womens health diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that breast cancer is expected to witness highest growth over the forecast period due to high occurrence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as abus.

Q7. In womens health diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to increasing prevalence of cancer among women.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the womens health diagnostic market by end use industry (hospitals & clinics, diagnostic & imaging centers, home care settings, and others), application (osteoporosis testing, ovc testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Womens Health Diagnostic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Womens Health Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Womens Health Diagnostic Market by End Use Industry Industry
  • 3.3.1: Hospitals & Clinics
  • 3.3.2: Diagnostic & Imaging Centers
  • 3.3.3: Home Care Settings
  • 3.3.4: Others
• 3.4: Global Womens Health Diagnostic Market by Application
  • 3.4.1: osteoporosis testing
  • 3.4.2: OVC testing
  • 3.4.3: cervical cancer testing
  • 3.4.4: breast cancer testing
  • 3.4.5: pregnancy & fertility testing
  • 3.4.6: prenatal genetic screening & carrier testing
  • 3.4.7: infectious disease testing
  • 3.4.8: STD testing
  • 3.4.9: ultrasound tests

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Womens Health Diagnostic Market by Region
• 4.2: North American Womens Health Diagnostic Market
  • 4.2.2: North American Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
• 4.3: European Womens Health Diagnostic Market
  • 4.3.1: European Womens Health Diagnostic Market by End Use Industry Industry: Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care Settings, and Others
  • 4.3.2: European Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
• 4.4: APAC Womens Health Diagnostic Market
  • 4.4.1: APAC Womens Health Diagnostic Market by End Use Industry Industry: Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care Settings, and Others
  • 4.4.2: APAC Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
• 4.5: ROW Womens Health Diagnostic Market
  • 4.5.1: ROW Womens Health Diagnostic Market by End Use Industry Industry: Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care Settings, and Others
  • 4.5.2: ROW Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Womens Health Diagnostic Market by End Use Industry Industry
  • 6.1.2: Growth Opportunities for the Global Womens Health Diagnostic Market by Application
  • 6.1.3: Growth Opportunities for the Global Womens Health Diagnostic Market by Region
• 6.2: Emerging Trends in the Global Womens Health Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Womens Health Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Womens Health Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: F. Hoffmann-la Roche
• 7.2: Siemens Aktiengesellschaft
• 7.3: Quest Diagnostics Incorporated
• 7.4: Ge Healthcare
• 7.5: Koninklijke Philips
• 7.6: General Motors
• 7.7: Abbott Laboratories
• 7.8: Becton
• 7.9: Dickinson
• 7.10: Hologic